Projects

Chosen filters:
Chosen filters:

1 - 10 of 164 results

Sorteren op
Search term:

COVID19 – TriVoice PLUS – Astra-Zeneca derde dosis, Vaccination against Covid-19 in cancer: booster shot BNT161b2 vaccine after full vaccination with ChAdOx1-S vaccine (Tri-VOICE plus). University of Antwerp

Eva Lion
Sciensano, Institute of Tropical Medicine Antwerp (ITM), Antwerp University Hospital (UZA), Laboratory for Experimental Hematology (LEH)
COVID-19 is a disease caused by an infectious outbreak of SARS-CoV-2. This viral SARS-CoV-2 infection can present itself in a broad spectrum of clinical features, ranging from asymptomatic, sensation of a mild cold or flu to severe bilateral pneumonia and death. Cancer patients are at high risk to develop serious illness after infection with SARS-CoV-2. Therefore, it is of high importance to protect these patients by following hygiene ...

Responding proactively to Covid-19 vaccination doubts to increase the effectiveness of vaccination campaigns in Belgium. KU Leuven

Anne-Mieke Vandamme
Laboratory of Clinical and Epidemiological Virology (Rega Institute), Environment and Health, Faculty of Business and Economics, Kulak Kortrijk Campus, Instituut voor Tropische Geneeskunde Ant, Institut Pasteur, LONDON SCHOOL OF HYGIENE AND TROPICAL ME

A transdisciplinary approach of the question of how to respond proactively to Covid-19 vaccination doubts to increase the effectiveness of vaccination campaigns in Belgium:;

ICF: Seasonal R21 mass vaccination for malaria elimination (SERVAL) Institute of Tropical Medicine

Umberto D'Alessando, Koen Peeters Grietens, Fatou Jaiteh
Socio-ecological Health Research, National Centre for Training & Research in Rural Health of Maferinyah, Guinea, Natl Malaria Control Program, University of Oxford
R21 is a safe and well tolerated novel pre-erythrocytic vaccine, with an overall protective efficacy in children of 75% against first or only clinical malaria episode and 74% against multiple episodes. Mathematical models suggest that mass vaccination with a pre-erythrocytic vaccine may substantially reduce malaria transmission. We will test this by implementing a cluster-randomized trial in two areas at the extremes of the malaria ...

Research to increase confidence in maternal vaccination by digital communication interventions. University of Antwerp

Kirsten Maertens
Product development, Media, ICT and interpersonal relations in Organisations and Society (MIOS), Antwerp Centre for Digital humanities and literary Criticism (ACDC), Centre for Computational Linguistics, Psycholinguistics and Sociolinguistics (CLiPS), Centre for the Evaluation of Vaccination (CEV)
Since pregnant women, fetuses and neonates are highly vulnerable to infectious diseases related morbidity and mortality, it of utmost important to understand barriers in the uptake of maternal vaccines to decrease vaccine hesitancy and increase vaccination coverage in fertile, pregnant and lactating women. Therefore a multidisciplinary team of experts at the University Antwerp is created, to investigate the different aspects of social media ...

Vaccination during pregnancy: unravelling the basic principles. University of Antwerp

Pierre Van Damme
Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO)
Despite the availability of successful universal pertussis vaccination programs, the disease remains an important global public health problem and is nowadays one of the most common vaccinepreventable diseases in the world. The highest incidence and disease burden can be found in infants below one year of age, too young to be completely protected by the currently available vaccines and vaccination schedules. To protect these vulnerable infants, ...

Cross-protection against epidemic and pandemic H3N2 influenza viruses in humans and swine by vaccination with heterovariant strains (PANFLUVAC-1) Ghent University

Eric Cox
Department of Translational Physiology, Infectiology and Public Health

Subsequent vaccination with antigenically very distinct influenza viruses of a given HA subtype (heterovariant vaccination) seems to be very effective in stimulating memory B cells that recognize conserved epitopes in the viral haemagglutinin (HA) and that produce broadly-reactive antibodies. Using this vaccination strategy we aim at a) protecting swine against European and North American H3N2 swine influenza viruses and b) protecting humans ...

Unraveling the Impact of Vaccination on Rinderpest Virus Evolution (EvoVax) KU Leuven

Philippe Lemey
Laboratory of Clinical and Epidemiological Virology (Rega Institute)

Rinderpest virus (RPV) was historically one of the most devastating pathogens affecting cattle, with a global impact unmatched by any other livestock disease. Although largely eradicated in Europe by the late 19th century, RPV continued causing catastrophic outbreaks in Africa and Asia, leading to severe economic and agricultural consequences. The introduction of a vaccine in the 1960s marked a turning point, ultimately leading to the ...

Vaccination, Infectious diseases, Antimicrobials and Immunotherapies: Data science from Cell to Policy (VAXINAID-C2P). (VAXINAID-C2P) University of Antwerp

Philippe Beutels
Laboratory for Experimental Hematology (LEH), Laboratory of Medical Microbiology (LMM), Centre for the Evaluation of Vaccination (CEV), Institutional Research Unit, Evolutionary ecology group (EVECO), Centre for Health Economics Research and Modelling of Infectious Diseases (CHERMID)
Infectious diseases (ID), immune responses (IR) and antimicrobial resistance (AMR) in humans and animals present complex challenges in a 'One Health' context. Five UAntwerpen research groups with strong international records and collaborations capitalize on their joint expertise to perform data driven science from the cellular level over the behavioral host-pathogen level to the public health policy level. CHERMID undertakes methodological and ...

Investigating gender and sex differences in immune responses through vaccination of transgender persons Ghent University

Isabel Leroux-Roels
Department of Internal Medicine and Pediatrics, Department of Diagnostic Sciences
Sexual dimorphism is a recognized source of variation in the immune system. In response to vaccines and infection, men experience dysbalanced inflammatory responses, more Treg differentiation and lower antibody titers, while women exhibit higher inflammation, better antigen presentation but more T cell exhaustion. The specific contributions of chromosomal and hormonal factors are incompletely understood but can be investigated in transgender ...